NAGIOS: RODERIC FUNCIONANDO

Malignant lymphoma of the oral cavity and the maxillofacial region: overall survival prognostic factors

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Malignant lymphoma of the oral cavity and the maxillofacial region: overall survival prognostic factors

dc.contributor.author	Guevara Canales, Janet Ofelia	es
dc.contributor.author	Morales Vadillo, Rafael	es
dc.contributor.author	Sacsaquispe Contreras, Sonia Julia	es
dc.contributor.author	Barrionuevo Cornejo, Carlos	es
dc.contributor.author	Montes Gil, Jaime	es
dc.contributor.author	Cava Vergiú, Carlos Enrique	es
dc.contributor.author	Soares, Fernando Augusto	es
dc.contributor.author	Chaves Netto, Henrique Duque de Miranda	es
dc.contributor.author	Chaves, Maria das Graças Afonso Miranda	es
dc.date.accessioned	2014-05-29T07:11:31Z
dc.date.available	2014-05-29T07:11:31Z
dc.date.issued	2013	es
dc.identifier.citation	Guevara Canales, Janet Ofelia ; Morales Vadillo, Rafael ; Sacsaquispe Contreras, Sonia Julia ; Barrionuevo Cornejo, Carlos ; Montes Gil, Jaime ; Cava Vergiú, Carlos Enrique ; Soares, Fernando Augusto ; Chaves Netto, Henrique Duque de Miranda ; Chaves, Maria das Graças Afonso Miranda. Malignant lymphoma of the oral cavity and the maxillofacial region: overall survival prognostic factors. En: Medicina oral, patología oral y cirugía bucal. Ed inglesa, 2013, Vol. 18, No. 4: 619-626	es
dc.identifier.uri	http://hdl.handle.net/10550/35644
dc.description.abstract	Objective: To identify the overall survival and prognostic factors of malignant lymphoma of the oral cavity and the maxillofacial region. Study Design: Clinical records data were obtained in order to determine overall survival at 2 and 5 years, the individual survival percentage of each possible prognostic factor with the actuarial technique, and the survival regarding the possible prognostic factors with the actuarial technique and the Log-rank and Cox's regression tests. Results: Of 151 subjects, an overall survival was 60% at 2 years, and 45% at 5 years. The multivariate analysis demonstrated statistically significant differences for clinical stage (p=0.002), extranodal involvement (p=0.030), presence of human immunodeficiency virus (p=0.032), and presence of Epstein-Barr virus (p=0.010). Conclusion: The advanced clinical stage and the larger number of involved extranodular sites are related to a lower overall survival, as well as, the presence of previous infections such as the human immunodeficiency and the Epstein-Barr virus.	en_US
dc.subject	Odontología	es
dc.subject	Ciencias de la salud	es
dc.title	Malignant lymphoma of the oral cavity and the maxillofacial region: overall survival prognostic factors	es
dc.type	journal article	es_ES
dc.subject.unesco	UNESCO::CIENCIAS MÉDICAS	es
dc.type.hasVersion	VoR	es_ES